Ticker brief

GKOS

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
9
authors 14d
7
crowd 14d
-1.4σ

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-10-07 → 2026-10-16 · now +0.00 (−1 bearish … +1 bullish)
Who spoke7
authorgradetrader scoresignalsmean sent
@OptionsFlowBossC·3+0.28
@HedgeFundTipsB+0.731+0.10
@Brad_E_SchulzC·1+0.45
@UTEX_ioC+0.041-0.15
@TickeronC+1.531-0.25
@BiopharmIQB·1-0.45
@ThePupOfWallStC-1.471+0.00
Recent signals9of 9 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-16@OptionsFlowBoss+0.00Shares GKOS open-interest changes without a textual directional interpretation.·
2026-10-15@OptionsFlowBoss+0.45Reports a $596K GKOS call buyer.·
2026-10-12@ThePupOfWallSt+0.00Adds GKOS to a CANSLIM scanner without giving a directional trade.·
2026-10-08@BiopharmIQ-0.45Summarizes large biotech moves and lists upcoming Phase 2 and Phase 3 catalysts.·
2026-10-08@Tickeron-0.25Reports an 11.58% decline despite a licensing deal, attributing weakness to profit-taking.·
2026-10-08@UTEX_io-0.15Glaukos signed an exclusive license for a retinal-disease biologic as shares fell sharply.·
2026-10-07@OptionsFlowBoss+0.40Lists unusually bullish options-volume multiples; output is capped at six tickers.·
2026-10-07@Brad_E_Schulz+0.45Lists stocks up at least 4% on elevated intraday volume; capped at six.·
2026-10-07@HedgeFundTips+0.10Presents a broad list of names receiving money flows, truncated to the first six tickers.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.